At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
Placebo +1 moredrug
Likely dose
Placebo 3mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Efficacy of Eszopiclone (Lunesta) for Chronic Insomnia Associated With Osteoarthritis.
In Brief
A clinical study evaluating Placebo and Eszopiclone for Osteoarthritis and Insomnia. Completed, enrolled 30 participants across 1 site.
Detailed Summary
This research is being done to evaluate the effects of a sleeping pill (eszopiclone, Lunesta)in patients with arthritis of the knee who also suffer from chronic insomnia. This study will test whether Lunesta improves sleep, pain sensitivity, and daytime symptoms in patients with knee pain.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis, Insomnia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2006
First PostedSep 2006
Primary CompletionDec 2013
TodayJul 2026
First PostedSep 11, 2006
Enrollment StartJan 1, 2006
Primary CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 7.9 yearsPosted 19.8 years ago
Interventions
Placebodrug
3mg placebo capsule, once daily at bedtime
Eszopiclonedrug
3mg capsule, once daily at bedtime